Company Officially Becomes Itself LLC in Drug Probe
Published Date: 5/19/2026
Notice
Summary
The U.S. International Trade Commission has approved updating the investigation papers to reflect that Ascendis Pharma changed its name to Ascendis Pharma, LLC. This affects companies involved in a patent dispute over certain drug products with C-type natriuretic peptide variants. No delays or extra costs are expected, so the investigation keeps moving forward smoothly.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20201, Chassis and Subassemblies From China; Scheduling of Expedited Five-Year Reviews
The U.S. International Trade Commission is speeding up its review to decide if tariffs on chassis and subassemblies from China should stay or go. This affects U.S. businesses that make or import these parts and could impact prices or trade rules starting July 6, 2026. The review is quicker than usual because only domestic groups responded fully, so expect a fast decision on whether to keep the duties.
2026-20188, Notice of Receipt of Complaint; Solicitation of Comments Relating to The Public Interest
The U.S. International Trade Commission got a complaint about certain magnet wires imported from China that might be breaking trade rules. They want to hear from the public and other businesses about how this could affect everyone before deciding on possible bans or orders. If you’re involved or interested, now’s the time to speak up—this could impact sales and imports soon!
2026-20208, Certain Storage Containers and Toolboxes, Organizers, Component Boxes, and Coolers; Notice of a Commission Determination To Find a Violation of Section 337; Issuance of Remedial Orders; Continued Proceedings as to One Patent; Extension of Target Date
The U.S. International Trade Commission found that some imported storage containers, toolboxes, and coolers violate patent rules. They’re ordering these products to be stopped from entering the U.S. and setting a bond of 18% of their value during a review period. The investigation deadline is now extended to November 2, 2026, while one patent is still under review.
2026-20081, Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint from Netlist, Inc. about certain DRAM memory products possibly breaking trade rules. Big tech companies like Micron, NVIDIA, Broadcom, and Google are involved, and the Commission wants your thoughts on how this might affect the public. If things move forward, there could be import bans or sales stops, with decisions happening within about 60 days.
2026-20137, Certain Tissue Paper Products From China; Institution of a Five-Year Review
The U.S. International Trade Commission is checking if stopping extra taxes on tissue paper from China would hurt American businesses. This review started on October 1, 2026, and anyone interested must send their info by November 2, 2026. The decision could affect prices and jobs in the tissue paper market.
2026-20139, Aluminum Foil From Armenia, Brazil, Oman, Russia, and Turkey; Institution of Five-Year Reviews
The U.S. International Trade Commission is checking if aluminum foil imports from Armenia, Brazil, Oman, Russia, and Turkey still need extra duties to protect American businesses. They want to know if stopping these duties would hurt U.S. foil makers. People involved have until November 2, 2026, to share their thoughts, so the Commission can decide what’s best.
Previous / Next Documents
Previous: 2026-10009, Sunshine Act Meetings
The Unified Carrier Registration (UCR) Task Force is holding a public meeting on May 27, 2026, to discuss updates to the UCR Plan and Agreement that affect carriers who register for interstate transportation. They’ll review past meeting notes, consider changes, and set the stage for smoother registration processes. No new fees or costs are mentioned, but staying tuned is key for carriers and stakeholders.
Next: 2026-10012, Advisory Committee on Immunization Practices (ACIP); Notice of Charter Re-Establishment
The CDC is officially bringing back the Advisory Committee on Immunization Practices (ACIP) for another two years after a paperwork mix-up caused a brief pause. This committee helps guide vaccine decisions that affect everyone’s health, so its return keeps important vaccine advice on track without extra costs or delays. The re-establishment shows the CDC’s commitment to keeping us safe and informed about immunizations.